European Pharmacopoeia

European Pharmacopoeia

The European Pharmacopoeia is published by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe in Strasbourg. The publication contains standardised specifications defining the quality of pharmaceutical preparations, their constituents and containers.

The Finnish Medicines Agency Fimea is the Finnish national authority in pharmacopoeia matters.

The European Pharmacopoeia can be ordered from:

  • EDQM Online Store
  • EDQM Publications, (European Pharmacopoeia), 7 allée Kastner, CS 30026, F-67081 Strasbourg, France; fax +33 3 88 41 27 71; e-mail: orders@edqm.eu

News

The eight supplement of the tenth edition of the European Pharmacopoeia (European Pharmacopoeia 10th Edition, Supplement 10.8) has been implemented on July 1st, 2022.

The National pharmacopoeia documents have been updated according to the eighth supplement of the tenth edition.

Fimea has reviewed the Finnish names of vaccine monographs in the European Pharmacopoeia. The Finnish spelling of almost all vaccine monograph names has been corrected.

It was considered necessary to review and correct the vaccine monograph names; inconsistencies were observed in the nomenclature. The new, revised translations mainly follow the English names of the vaccine monographs, in consideration of the characteristics of Finnish. There are some exceptions to the general rule: for example, the traditional abbreviations used in the names of animal vaccines in Finland have been preserved.

The corrected names are included in the List of monographs provided in the National pharmacopoeia documents. Updated names are also provided as a separate listing.